About Eximis Surgical

Eximis Surgical develops a fully contained device that enables surgeons to remove large specimens through small incisions, enhancing the practice of minimally invasive surgery. This technology reduces incision sizes from up to 7 cm to significantly smaller openings, resulting in less postoperative pain and shorter hospital stays for approximately 2 million patients annually.

```xml <problem> Many minimally invasive surgeries still require larger incisions (up to 7cm) at the end of the procedure for specimen removal, negating some of the benefits of the minimally invasive approach. This can lead to increased post-operative pain, longer hospital stays, and delayed return to normal activities for patients. </problem> <solution> Eximis Surgical is developing a fully contained device designed to enable surgeons to remove large specimens through significantly smaller incisions during minimally invasive surgery. This technology aims to maintain the benefits of minimally invasive techniques throughout the entire procedure, from start to finish. By reducing the size of the incision needed for specimen removal, the device intends to minimize post-operative pain and shorten hospital stays, allowing patients to recover faster and return to their normal routines sooner. The device offers a fast, easy, and safe solution for specimen extraction. </solution> <features> - Fully contained system for specimen removal. - Designed for use in a variety of minimally invasive surgical procedures. - Aims to reduce incision size compared to traditional specimen removal methods. </features> <target_audience> The primary target audience includes surgeons performing minimally invasive procedures, particularly those in gynecologic oncology and general surgery, as well as patients seeking less invasive surgical options. </target_audience> ```

What does Eximis Surgical do?

When was Eximis Surgical founded?

Eximis Surgical was founded in 2014.

How much funding has Eximis Surgical raised?

Eximis Surgical has raised 15300000.

Founded

2014

Funding

15300000

Employees

14 employees

Major Investors

Questa Capital Management

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Eximis Surgical

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

eximissurgical.com 700+

Crunchbase

Founded 2014

Funding

Estimated Funding

$10M+

Major Investors

Questa Capital Management

Team (10+)

No team information available.

Company Description

Problem

Many minimally invasive surgeries still require larger incisions (up to 7cm) at the end of the procedure for specimen removal, negating some of the benefits of the minimally invasive approach. This can lead to increased post-operative pain, longer hospital stays, and delayed return to normal activities for patients.

Solution

Eximis Surgical is developing a fully contained device designed to enable surgeons to remove large specimens through significantly smaller incisions during minimally invasive surgery. This technology aims to maintain the benefits of minimally invasive techniques throughout the entire procedure, from start to finish. By reducing the size of the incision needed for specimen removal, the device intends to minimize post-operative pain and shorten hospital stays, allowing patients to recover faster and return to their normal routines sooner. The device offers a fast, easy, and safe solution for specimen extraction.

Features

Fully contained system for specimen removal.

Designed for use in a variety of minimally invasive surgical procedures.

Aims to reduce incision size compared to traditional specimen removal methods.

Target Audience

The primary target audience includes surgeons performing minimally invasive procedures, particularly those in gynecologic oncology and general surgery, as well as patients seeking less invasive surgical options.